secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2022-07-22T23:59:59+00:00
Accession:  0001683168-22-005083
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals appoints CEO to board, amends exec agreements, CFO to resign amid office consolidation
--------------------------------------------------------------------------------

- CEO Amy Trombly appointed to board effective July 22, 2022; amended employment agreement with severance of one-time base salary.
- COO Bruce Thornton agreement amended; change-in-control bonus of 50% of base salary added.
- CFO Jerry Dvonch resigns effective on/before Dec 31, 2022; severance of $100,000 plus COBRA and equity acceleration.
- Annual bonus grants approved: $162,500 for Trombly, $150,000 for Thornton.
- Company consolidating to Boulder, CO; closing Woodstock, GA office as part of cost-cutting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/snoa_i8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-005083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer